Newborn, Infant, Disease

1

Review clinical trials related to Newborn, Infant, Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Perinatal Covid-19 Infection, NO Pathway, and Minipuberty

Some evidence exists that SARS-COV-2 may infect pituitary axis, and therefore may alter hypothalamic function. Whether perinatal COVID-19 is associated with alterations in the maturation of the Hypothalamic-Pituitary-Gonadal (HPG) axis, and specifically with its transient activation occurring during infancy, namely minipuberty, is a major concern. Among the various pathogenic features related to COVID-19, altered minipuberty could be a key factor underlying many multimorbidities later in life, suggesting that they could involve a common causative mechanism that occurs within this short and critical period of time following birth. Altered minipuberty together with NO deficiency seem to be key factors underlying many of these multimorbidities, suggesting that they involve a common causative mechanism that occurs within this short and critical period of time following birth

Participants needed: 180
Trial details
Age: Up to 3Biological sex: AllType: ObservationalSponsor: University Hospital, LilleUpdated: May 20, 2026Locations: 2
Eligibility criteria

Antenatal COVID-19 infection: pregnant women with positive PCR test at any time... [+6]

Preterm birth less than 24 weeks gestational age. [+2]